NIH

Dear Research Advocate, Women in Science and Technology : March is Women’s History Month. The impact of COVID-19 on the careers of women in STEMM is the focus of a report to be released by the National Academies of Science, Engineering, and Medicine (NASEM) on March 9, 2021. How did the COVID-19 pandemic disrupt the careers of women in academic STEMM during 2020 and how might these disruptions—both positive and negative—shape future progress for women in academic STEMM? The public is invited to a discussion with NASEM committee members Eve J. Higginbotham, University of Pennsylvania; Reshma Jagsi, University of Michigan; and Erick C. Jones, University of Texas at Arlington. Register here ...
Dear Research Advocate, Public Support for a Science Strong Future : A new survey commissioned by Research!America affirms Americans’ support for investing in research as a top priority for the new Congress and Administration. Four of five express strong support for the value of both public and private sector research and innovation, and the percentage of Americans indicating support for basic research “even if it brings no immediate benefits” grew from 77% in August 2020 to 85% in January 2021, with three of four now favoring doubling federal spending on medical research. As reassuring as the new survey data is in most regards, one in five Americans say they have lost confidence in science...
This is the first in a series of blog posts exploring COVID-19 from a women’s health perspective. On October 20, 2020, the Office for Women’s Health Research (ORWH) at the National Institute of Health (NIH) held its 51st Meeting of the NIH Advisory Committee on Research on Women’s Health. The panel titled, “COVID-19 and the Health of Women” featured insightful presentations on the pandemic’s distinctive impact on women's health. This blog series will explore each of the three sessions. Panelists reported mounting evidence that COVID-19 may affect women and men differently. Although men and women are infected at the same rate, more men than women are dying from this virus. Why is this...
This is the second in a series of blog posts exploring COVID-19 from a women’s health perspective. On October 20, 2020, the Office for Women’s Health Research (ORWH) at the National Institute of Health (NIH) held its 51st Meeting of the NIH Advisory Committee on Research on Women’s Health. The panel titled “COVID-19 and the Health of Women” featured insightful presentations on the pandemic’s distinctive impact on women's health. This blog series will explore each of the three sessions. In the second presentation of the panel, Dr. Neel Shah described the effects COVID-19 has had on pregnant people and their health care. It is unclear if pregnant people are more likely to be severely infected...
This is the third in a series of blog posts exploring COVID-19 from a women’s health perspective. On October 20, 2020, the Office for Women’s Health Research (ORWH) at the National Institute of Health (NIH) held its 51st Meeting of the NIH Advisory Committee on Research on Women’s Health. The panel titled “COVID-19 and the Health of Women” featured insightful presentations on the pandemic’s distinctive impact on women's health. This blog series will explore each of the three sessions. In the final presentation of the panel on COVID-19 and the health of women, Dr. Monica Webb Hooper stressed that to achieve health equity, it is important to understand the health of underserved women. This...
The challenges of life during the COVID-19 pandemic are greatly magnified for those with chronic illnesses, who may have less access to needed care and support. This is especially true when those health conditions make them more susceptible to contracting or becoming seriously ill from COVID-19. People with substance use disorders or who are struggling to recover fall squarely in this category and research is urgently needed on the intersections of COVID-19 and substance use and related health issues. Such research could not only benefit some of the most vulnerable groups, but valuably inform efforts to address the pandemic more generally. People with substance use disorders are potentially...
Dear Research Advocate, Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials. That science has moved so quickly from first identification of the virus to Phase 3 trials, speaks to remarkable public-private sector collaboration. It also speaks to the absolute necessity of taxpayer investment in basic, discovery science over many years; a lesson we must not ignore as we plan responses to the pandemics that will surely follow. To help move the massive trial enrollment process along, NIH has launched the COVID-19 Prevention Trials Network (COVPN), merging networks already funded by NIAID for HIV and other infectious disease trials. Each of the Phase 3 clinical...
Dear Research Advocate, We lost two extraordinary Civil Rights heroes this past weekend, John Lewis and C.T. Vivian. Of these courageous, committed advocates, Dr. Louis Sullivan, former HHS Secretary, Research!America emeritus board member, and friend to research advocacy, said in a statement: “ The lives of millions are better today because of their leadership and their sacrifice .” AAAS has begun a “transition to a lifelong commitment of actions to eradicate anti-Black racism in academia and STEM.” AAAS CEO and Research!America board member Dr. Sudip Parikh is leading the three-phase effort. You can review the first phase of the draft plan now. AAAS welcomes your feedback; please email...
Dear Research Advocate, Our nation is ailing; anxious and eager for healing and for solutions that can seem out of reach. Research!America often speaks about science as a way to ‘find the solutions to what ails us’ – given the opportunity, science has and will continue to deliver solutions. But it isn’t only science that we need right now, as gaping wounds of injustice against black Americans assail us. Advocacy and action are needed to assure a fair and just society. Alexis de Tocqueville, that enduringly wise observer of our nation, said: “The greatness of America lies not in being more enlightened than any other nation, but rather in her ability to repair her faults.” Let’s all get to...
Dear Research Advocate, “We are in the profession that aims to come up with answers. We have a mission and a noble one. I often like to point out while our initials are NIH….in circumstances like this we’re the National Institutes of Hope. While fear, anxiety, and stress are all around us, hope can be contagious.” —Francis Collins, MD, PhD Earlier today, Dr. Francis Collins, Director of the National Institutes of Health (NIH), joined us on our alliance member call to provide an overview of NIH’s unprecedented Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) , a partnership between industry and governmental leaders working to speed COVID-19 vaccines and treatments. Dr...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient